Announced
Completed
Financials
Tags
Venture Capital
Completed
Single Bidder
Private
Friendly
Cross Border
Acquisition
Minority
Private Equity
China
Pharmaceuticals
health care
pharmaceutical
Synopsis
Prosperity7 Ventures, a venture capital fund, led a $47m Series B round in Full-Life Technologies, a fully integrated global radiotherapeutics company, with participation from Sky9 Capital, Summer Capital, and GuanghuaWutong Fund, Chengwei Capital, HongShan, and Junson Capital. "The financing reflects strong support from our new and existing investors of our strategy and faith in the significant progress we have made in just over two years to build a fully integrated radiopharmaceutical company. The funding will support our evolution into a clinical-stage company, the advancement of our pipeline programs, and the construction of a Good Manufacturing Practices (GMP) manufacturing facility," Julie Wu, Full-Life Technologies CFO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.